Cargando…
Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570706/ https://www.ncbi.nlm.nih.gov/pubmed/28852564 http://dx.doi.org/10.1093/jlb/lsx002 |
| _version_ | 1783259208848769024 |
|---|---|
| author | Patel, Nisarg A. |
| author_facet | Patel, Nisarg A. |
| author_sort | Patel, Nisarg A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5570706 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55707062017-08-29 Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices Patel, Nisarg A. J Law Biosci New Developments Oxford University Press 2017-04-03 /pmc/articles/PMC5570706/ /pubmed/28852564 http://dx.doi.org/10.1093/jlb/lsx002 Text en © The Author 2017. Published by Oxford University Press on behalf of Duke University School of Law, Harvard Law School, Oxford University Press, and Stanford Law School. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | New Developments Patel, Nisarg A. Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices |
| title | Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices |
| title_full | Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices |
| title_fullStr | Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices |
| title_full_unstemmed | Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices |
| title_short | Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices |
| title_sort | fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices |
| topic | New Developments |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570706/ https://www.ncbi.nlm.nih.gov/pubmed/28852564 http://dx.doi.org/10.1093/jlb/lsx002 |
| work_keys_str_mv | AT patelnisarga feeforvalueinthepharmaceuticalindustryapolicyframeworkapplyingdatasciencetonegotiatedrugprices |